References
- Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria – 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291–2.
- Harrison D, Mehta P, van Es MA, Stommel E, Drory VE, Nefussy B, et al. “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:495–9.
- Bedlack RS, Vaughan T, Wicks P, Heywood J, Sinani E, Selsov R, et al. How common are ALS plateaus and reversals? Neurology 2016;86:808–12.
- Bedlack RS. Unpublished Data. 2021.
- Su F-C, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:803–11.
- Oskarsson B, Horton DK, Mitsumoto H. Potential environmental factors in amyotrophic lateral sclerosis. Neurol Clin. 2015;33:877–88.
- 110th Congress. An act to amend the public health service act to provide for the establishment of an amyotrophic lateral sclerosis registry; 2008:4047–4050. Available at: https://wwwn.cdc.gov/als/Download/ALSRegistryAct(PublicLaw110-373).pdf
- Centers for Disease Control and Prevention. National ALS Registry. Available at: https://www.cdc.gov/als/
- Center for Science in the Public Interest. Caffeine Chart. Published 2021. Available at: https://cspinet.org/eating-healthy/ingredients-of-concern/caffeine-chart. Accessed April 5, 2021.
- United States Census Bureau. North American Industry Classification System. Published 2021. Available at: https://www.census.gov/naics/. Accessed October 2, 2021.
- Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
- Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harb Perspect Med. 2017;7:a024117.
- Bradley WG, Andrew AS, Traynor BJ, Chiò A, Butt TH, Stommel EW. Gene-environment-time interactions in neurodegenerative diseases: hypotheses and research approaches. Ann Neurosci. 2018;25:261–7.
- Study of ALS Reversals 2: Genetic Analyses (StAR2). Available at: https://clinicaltrials.gov/ct2/show/NCT03464903